Related to Domainex to Provide Sigma-Aldrich with Expertise to Enable Study of Epigenetic Proteins

• Evotec, Dana-Farber Partner on Cancer Epigenetics Drug Development
  
• Epigenetic Changes Predict Postpartum Depression
  
• Domainex to Conduct Optimization for U.K. Asthma Drug Collaboration
  
• Tocris and Sigma-Aldrich to Supply Pfizer Molecules for Research Use
  
• Sigma-Aldrich to Provide Gene Synthesis Services to Gene Oracle
  
• Sigma-Aldrich and Sangamo Biosciences Broaden Agreement Related to Zinc-Finger Technology
  
• Sigma-Aldrich Licenses Polyplus Transfection’s ZNA Oligos for Research Use
  
• Sigma-Aldrich to Distribute Stemgent’s Gene Delivery Products for iPS Cells
  
• Sigma-Aldrich to Offer Eka’s HPLC Columns
  
• Sigma-Aldrich Licenses RAFT Polymerization Technology from CSIRO
  
• Sigma-Aldrich, NHLBI, and Boston University to Mine Framingham Study for CVD Biomarkers
  
• Sigma Life Science and SwitchGear Genomics to Develop miRNA Target-Validation System
  
• Sigma Life Science to Provide Oligonucleotides to Research Councils UK
  
• Jackson Laboratory to Distribute Sigma Life Sciences' Transgenic Mice
  
• Plasticell and Sigma-Aldrich Partner on Stem Cell Differentiation Tools
  
• Sigma Life Science and Cofactor Genomics to Sequence Six Rat Genomes
  
• Kraig Licenses Sigma’s ZFN Platform to Generate Spider Silk-Spinning Silkworms
  
• Sigma Life Science Gains Rights to iPSC Technology from iPS Academia Japan
  
• Sigma-Aldrich, UIUC Ink Membrane Scaffold Protein Deal for Nanodisc Technology
  
• Roche and Sigma-Aldrich to Co-Market Complementary Platforms for Epigenetic Research